Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femoro-Popliteal Lesions

NCT06734221 is registered in ClinicalTrials.gov with Balton Sp.zo.o. as lead sponsor.

NCT NCT06734221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06734221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femoro-Popliteal Lesions
Lead sponsor
Balton Sp.zo.o.
Phase
Not applicable
Overall status
Recruiting
Start date
September 15, 2024
Completion date
September 15, 2026
Enrollment
120 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral artery disease, popliteal artery stenosis above the knee, superficial femoral artery stenosis